CROHN’S DISEASE: EPIDEMIOLOGY, PATHOPHYSIOLOGY, DIAGNOSIS, MANAGEMENT – A LITERATURE REVIEW
Abstract
Introduction and purpose: Crohn’s Disease (CD) is a condition characterized by chronic granulomatous inflammation that penetrates all layers of the intestinal wall and can affect any part of the gastrointestinal tract – from the oral cavity to the anus. This condition may be accopanied by extraintestinal manifestations. CD carries numerous complications that negatively impact patients’ well-being. The course of the disease is chronic with alternating periods of exacerbation and remission; nevertheless, symptoms are often persistant. This review summarizes the current knowledge, focusing on pathopisiology, epidemiology, diagnosis and treatment. By integrating current knowledge and new findings, it aims to enhance and optimize patient care.
Description of the State of Knowledge: Crohn’s disease is a condition with an incompletely understoos etiopathogenesis, in which disturbances in the microbiota – modulated by environmental factors (including diet) – are considered a likely cause, with genetic mutations contributing to susceptibility. Clinical diagnosis of the disease can be challenging, and faecal calprotectin may be a useful tool not only for diagnosis but also for monitorig disease activity. The introduction of biological therapies, particularly anti-TNF antibodies, has demonstrated satisfactory therapeutic efficacy.
Conclusions: The „treat-to-target” startegy in therapy provides optimal conditions as long as continuous monitoring and assessment of treatment outcomesare maintained. The lack of standardized treatment methods allows for a wide range of therapeutic approaches; nevertheless, complications leading to surgical intervations remain a major clinical challenge.
Matherials and methods: A review of recent clinical studies and scientific articles was conducted, focusing primarily on pathophysiology, epidemiology, clinical presentation, diagnosis and treatment, suplemeted with the latest findings.
References
Veauthier, B., & Hornecker, J. R. (2018). Crohn’s disease: Diagnosis and management. American Family Physician, 98(11), 661–669.
Baumgart, D. C., & Sandborn, W. J. (2012). Crohn’s disease. The Lancet, 380(9853), 1590–1605. https://doi.org/10.1016/S0140-6736(12)60026-9
Carnazzo, V., Redi, S., Basile, V., Natali, P., Gulli, F., Equitani, F., Marino, M., & Basile, U. (2024). Calprotectin: Two sides of the same coin. Rheumatology, 63(1), 26–33. https://doi.org/10.1093/rheumatology/kead405
Mitchel, E. B., & Rosh, J. R. (2022). Pediatric management of Crohn’s disease. Gastroenterology Clinics of North America, 51(2), 401–424. https://doi.org/10.1016/j.gtc.2021.12.013
Gasparetto, M., & Guariso, G. (2014). Crohn’s disease and growth deficiency in children and adolescents. World Journal of Gastroenterology, 20(37), 13219–13233. https://doi.org/10.3748/wjg.v20.i37.13219
Carter, M., & Lim, I. I. P. (2024). Surgical management of pediatric Crohn’s disease. Seminars in Pediatric Surgery, 33(2), Article 151401. https://doi.org/10.1016/j.sempedsurg.2024.151401
Schneider, S. L., Foster, K., Patel, D., & Shwayder, T. (2018). Cutaneous manifestations of Crohn’s disease in children. Pediatric Dermatology, 35(5), 566–574. https://doi.org/10.1111/pde.13565
Shehada, M., & McMahon, L. E. (2024). Recurrent Crohn’s disease. Seminars in Pediatric Surgery, 33(2), Article 151403. https://doi.org/10.1016/j.sempedsurg.2024.151403
Spinelli, A., Sacchi, M., Fiorino, G., Danese, S., & Montorsi, M. (2011). Risk of postoperative recurrence and postoperative management of Crohn’s disease. World Journal of Gastroenterology, 17(27), 3213–3219. https://doi.org/10.3748/wjg.v17.i27.3213
Huang, Z. C., Yang, Q. F., Tang, J., Li, M., Chao, K., & Gao, X. (2021). Thiopurines are superior to mesalamine for preventing postoperative recurrence in patients with Crohn’s disease and two or more risk factors. Journal of Digestive Diseases, 22(10), 590–596. https://doi.org/10.1111/1751-2980.13047
Brusaferro, A., Cavalli, E., Farinelli, E., Cozzali, R., Prin, N., & Esposito, S. (2019). Gut dysbiosis and paediatric Crohn’s disease. Journal of Infection, 78(1), 1–7. https://doi.org/10.1016/j.jinf.2018.10.005
Gunasekeera, V., Mendall, M. A., Chan, D., & Kumar, D. (2016). Treatment of Crohn’s disease with an IgG4-guided exclusion diet: A randomized controlled trial. Digestive Diseases and Sciences, 61(4), 1148–1157. https://doi.org/10.1007/s10620-015-3987-z
Wellens, J., Vermeire, S., & Sabino, J. (2021). Let food be thy medicine—Its role in Crohn’s disease. Nutrients, 13(3), Article 832. https://doi.org/10.3390/nu13030832
Levine, A., Wine, E., Assa, A., Sigall Boneh, R., Shaoul, R., Kori, M., … Van Limbergen, J. (2019). Crohn’s disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology, 157(2), 440–450.e8. https://doi.org/10.1053/j.gastro.2019.04.021
Ma, J., Chong, J., Qiu, Z., Wang, Y., Chen, T., & Chen, Y. (2024). Efficacy of different dietary therapy strategies in active pediatric Crohn’s disease: A systematic review and network meta-analysis. PeerJ, 12, e18692. https://doi.org/10.7717/peerj.18692
Petagna, L., Antonelli, A., Ganini, C., Bellato, V., Campanelli, M., Divizia, A., … Sica, G. S. (2020). Pathophysiology of Crohn’s disease inflammation and recurrence. Biology Direct, 15(1), Article 23. https://doi.org/10.1186/s13062-020-00280-5
Segal, A. W. (2019). Studies on patients establish Crohn’s disease as a manifestation of impaired innate immunity. Journal of Internal Medicine, 286(4), 373–388. https://doi.org/10.1111/joim.12945
Mignini, I., Blasi, V., Termite, F., Esposto, G., Borriello, R., Laterza, L., … Zocco, M. A. (2024). Fibrostenosing Crohn’s disease: Pathogenetic mechanisms and new therapeutic horizons. International Journal of Molecular Sciences, 25(12), Article 6326. https://doi.org/10.3390/ijms25126326
Noor, N. M., Lee, J. C., Bond, S., Dowling, F., Brezina, B., Patel, K. V., … PROFILE Study Group. (2024). A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn’s disease (PROFILE). The Lancet Gastroenterology & Hepatology, 9(5), 415–427. https://doi.org/10.1016/S2468-1253(24)00034-7
Bohra, A., Mohamed, G., Vasudevan, A., Lewis, D., Van Langenberg, D. R., & Segal, J. P. (2023). The utility of faecal calprotectin, lactoferrin and other faecal biomarkers in discriminating endoscopic activity in Crohn’s disease: A systematic review and meta-analysis. Biomedicines, 11(5), Article 1408. https://doi.org/10.3390/biomedicines11051408
Alyami, A. S., Madkhali, Y., Majrashi, N. A., Alwadani, B., Elbashir, M., Ali, S., … Refaee, T. (2024). The role of molecular imaging in detecting fibrosis in Crohn’s disease. Annals of Medicine, 56(1), Article 2313676. https://doi.org/10.1080/07853890.2024.2313676
Law, C. C. Y., Tkachuk, B., Lieto, S., Narula, N., Wals, S., Colombel, J. F., & Ungaro, R. C. (2024). Early biologic treatment decreases risk of surgery in Crohn’s disease but not in ulcerative colitis: Systematic review and meta-analysis. Inflammatory Bowel Diseases, 30(7), 1080–1086. https://doi.org/10.1093/ibd/izad149
Mourad, F. H., Maalouf, R. G., Aoun, R., Kotze, P. G., & Hashash, J. G. (2024). Are the new biologics effective in the management of postoperative Crohn’s disease? Inflammatory Bowel Diseases, 30(3), 459–469. https://doi.org/10.1093/ibd/izad033
Duan, S., Chen, P., Liang, C., & Zhang, Y. (2025). Comparative efficacy of novel biologics, anti–tumor necrosis factor agents, and immunomodulators to prevent postoperative recurrence in Crohn’s disease: A systematic review and network meta-analysis. Journal of Crohn’s and Colitis, 19(2), Article jjae143. https://doi.org/10.1093/ecco-jcc/jjae143
Ananthakrishnan, A. N. (2015). Epidemiology and risk factors for inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology, 12(4), 205–217. https://doi.org/10.1038/nrgastro.2015.34
Copyright (c) 2025 Karol Józef Szkarłat, Mateusz Kęska, Michael Platschek, Michał Drabik, Klaudia Dybalska, Maksym Sikora, Sylwia Wiktoria Kolano, Jakub Nowak, Anna Barbara Tuleja, Julia Kosmulska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
